• Explore /
  • Poster
  • / Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19).

Depth of PSA nadir and subsequent PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19).

Abstract Poster

Authors

null

Rahul Raj Aggarwal

University of California, San Francisco, San Francisco, CA

Rahul Raj Aggarwal , Katherine Dooley , David W. Hillman , Han Xiao , Joel Picus , Mary-Ellen Taplin , Tanya B. Dorff , Leonard Joseph Appleman , Douglas Jay Weckstein , Akash Patnaik , Alan Haruo Bryce , Daniel H. Shevrin , James L. Mohler , Daniel M. Anderson , Glenn Heller , Susan Halabi , Alan Tan , Scott E. Eggener , Charles J. Ryan , Michael J. Morris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT03009981

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5077)

DOI

10.1200/JCO.2023.41.16_suppl.5077

Abstract #

5077

Poster Bd #

171

Abstract Disclosures

Similar Posters

First Author: Rahul Raj Aggarwal

First Author: Ronald C. Chen

First Author: Benjamin H. Lowentritt

First Author: Fernando Cotait Maluf